Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report
This work is licensed under the Creative Commons Attribution 4.0 International License.
Classification International Society for the Study of Vascular Anomalies. [Internet]. [cited 2023 May 16]. Available at: https://www.issva.org/classification[cited 2023 May 16]. Available at: https://www.issva.org/classificationSearch in Google Scholar
Wu IC, Orbach DB. Neurointerventional management of high-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 2009; 19: 219–40. doi: 10.1016/j.nic.2009.01.005.WuICOrbachDBNeurointerventional management of high-flow vascular malformations of the head and neck2009192194010.1016/j.nic.2009.01.005Open DOISearch in Google Scholar
Sadick M, Wohlgemuth WA, Huelse R, Lange B, Henzler T, Schoenberg SO, et al. Interdisciplinary management of head and neck vascular anomalies: clinical presentation, diagnostic findings and minimalinvasive therapies. Eur J Radiol Open 2017; 4: 63–8. doi: 10.1016/j.ejro.2017.05.001SadickMWohlgemuthWAHuelseRLangeBHenzlerTSchoenbergSOInterdisciplinary management of head and neck vascular anomalies: clinical presentation, diagnostic findings and minimalinvasive therapies2017463810.1016/j.ejro.2017.05.001Open DOISearch in Google Scholar
Hage AN, Beecham Chick JF, Srinivasa RN, Bundy JJ, Chauhan NR, Acord M, et al. Treatment of venous malformations: the data, where we are, and how it is done. Tech Vasc Interv Radiol 2018; 21: 45–54. doi: 10.1053/j.tvir.2018.03.001HageANBeecham ChickJFSrinivasaRNBundyJJChauhanNRAcordMTreatment of venous malformations: the data, where we are, and how it is done201821455410.1053/j.tvir.2018.03.001Open DOISearch in Google Scholar
Horbach SER, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CMF, Rothová A, Van Der Horst CMAM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016; 69: 295–304. doi: 10.1016/j.bjps.2015.10.045HorbachSERLokhorstMMSaeedPde Goüyon Matignon de PontouraudeCMFRothováAVan Der HorstCMAMSclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents20166929530410.1016/j.bjps.2015.10.045Open DOISearch in Google Scholar
Maria L De, Sanctis P De, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for venous malformations of head and neck: systematic review and meta-analysis. Neurointervention 2020; 15: 4. doi: 10.5469/neuroint.2019.00213MariaL DeSanctisP DeBalakrishnanKTollefsonMBrinjikjiWSclerotherapy for venous malformations of head and neck: systematic review and meta-analysis202015410.5469/neuroint.2019.00213Open DOISearch in Google Scholar
Johnson AB, Richter GT. Surgical considerations in vascular malformations. Tech Vasc Interv Radiol 2019; 22: 100635. doi: 10.1016/j.tvir.2019.100635JohnsonABRichterGTSurgical considerations in vascular malformations20192210063510.1016/j.tvir.2019.100635Open DOISearch in Google Scholar
Wang YJ, Fletcher R, Yu J, Zhang L. Immunogenic effects of chemotherapy-induced tumor cell death. Genes Dis 2018; 5: 194. doi: 10.1016/j.gendis.2018.05.003WangYJFletcherRYuJZhangLImmunogenic effects of chemotherapy-induced tumor cell death2018519410.1016/j.gendis.2018.05.003Open DOISearch in Google Scholar
Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021; 47: 1836–1846. doi: 10.1016/j.ejso.2021.03.229SersaGUrsicKCemazarMHellerRBosnjakMCampanaLGBiological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap2021471836184610.1016/j.ejso.2021.03.229Open DOISearch in Google Scholar
Ursic K, Kos S, Kamensek U, Cemazar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release 2021; 332: 623–35. doi: 10.1016/j.jconrel.2021.03.009UrsicKKosSKamensekUCemazarMMiceskaSMarkelcBPotentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status20213326233510.1016/j.jconrel.2021.03.009Open DOISearch in Google Scholar
Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16: 295–320. doi: 10.1146/annurev-bioeng-071813-104622YarmushMLGolbergASersaGKotnikTMiklavcicDElectroporation-based technologies for medicine: principles, applications, and challenges20141629532010.1146/annurev-bioeng-071813-104622Open DOISearch in Google Scholar
Kesar U, Markelc B, Jesenko T, Valentinuzzi KU, Cemazar M, Strojan P, et al. Effects of electrochemotherapy on immunologically important modifications in tumor cells. Vaccines 2023; 11: 925. doi: 10.3390/vaccines11050925KesarUMarkelcBJesenkoTValentinuzziKUCemazarMStrojanPEffects of electrochemotherapy on immunologically important modifications in tumor cells20231192510.3390/vaccines11050925Open DOISearch in Google Scholar
Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315–27. doi: 10.1007/s00262-015-1724-2SersaGTeissieJCemazarMSignoriEKamensekUMarshallGElectrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer20156413152710.1007/s00262-015-1724-2Open DOISearch in Google Scholar
Groselj A, Bosnjak M, Jesenko T, Cemazar M, Markelc B, Strojan P, et al. Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol. Radiol Oncol 2022; 56: 398–408. doi: 10.2478/raon-2022-0021GroseljABosnjakMJesenkoTCemazarMMarkelcBStrojanPTreatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol20225639840810.2478/raon-2022-0021Open DOISearch in Google Scholar
Conforti A, Marra E, Palombo F, Roscilli G, Ravà M, Fumagalli V, et al. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models. Mol Ther 2022; 30: 311–26. doi: 10.1016/j.ymthe.2021.09.011ConfortiAMarraEPalomboFRoscilliGRavàMFumagalliVCOVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models2022303112610.1016/j.ymthe.2021.09.011Open DOISearch in Google Scholar
Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45: 92–102. doi: 10.1016/j.ejso.2018.11.023CampanaLGEdhemovicISodenDPerroneAMScarpaMCampanacciLElectrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration2019459210210.1016/j.ejso.2018.11.023Open DOISearch in Google Scholar
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020CloverAJPde TerlizziFBertinoGCuratoloPOdiliJCampanaLGElectrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)2020138304010.1016/j.ejca.2020.06.020Open DOISearch in Google Scholar
Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68–72. doi: 10.1016/0277-5379(91)90064-KMirLMOrlowskiSBelehradekJPaolettiCElectrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses199127687210.1016/0277-5379(91)90064-KOpen DOISearch in Google Scholar
Wang M, Duan Y, Yang M, Guo Y, Li F, Wang J, et al. The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells. Front Cell Dev Biol 2023; 11: 1146195. doi: 10.3389/fcell.2023.1146195WangMDuanYYangMGuoYLiFWangJThe analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells202311114619510.3389/fcell.2023.1146195Open DOISearch in Google Scholar
Polajzer T, Jarm T, Miklavcic D. Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro. Radiol Oncol 2020; 54: 317–328. doi: 10.2478/raon-2020-0047PolajzerTJarmTMiklavcicDAnalysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro20205431732810.2478/raon-2020-0047Open DOISearch in Google Scholar
Campana LG, Peric B, Mascherini M, Spina R, Kunte C, Kis E, et al. Combination of pembrolizumab with electrochemotherapy in cutaneous metastases from melanoma: a comparative retrospective study from the inspect and slovenian cancer registry. Cancers 2021; 13: 4289. doi: 10.3390/cancers13174289CampanaLGPericBMascheriniMSpinaRKunteCKisECombination of pembrolizumab with electrochemotherapy in cutaneous metastases from melanoma: a comparative retrospective study from the inspect and slovenian cancer registry202113428910.3390/cancers13174289Open DOISearch in Google Scholar
Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35: 672–7. doi: 10.1016/S0959-8049(98)00426-2SersaGCemazarMParkinsCSChaplinDJTumour blood flow changes induced by application of electric pulses199935672710.1016/S0959-8049(98)00426-2Open DOISearch in Google Scholar
Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta Gen Subj 2002; 1569: 51–8. doi: 10.1016/S0304-4165(01)00233-1GehlJSkovsgaardTMirLMVascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery2002156951810.1016/S0304-4165(01)00233-1Open DOISearch in Google Scholar
Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729–46. doi: 10.1586/era.10.43.JarmTCemazarMMiklavcicDSersaGAntivascular effects of electrochemotherapy: implications in treatment of bleeding metastases2010107294610.1586/era.10.43Open DOISearch in Google Scholar
Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One 2013; 8: e59557 doi: 10.1371/journal.pone.0059557MarkelcBSersaGCemazarMDifferential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels20138e5955710.1371/journal.pone.0059557Open DOISearch in Google Scholar
Markelc B, Bellard E, Sersa G, Jesenko T, Pelofy S, Teissié J, et al. Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions. J Control Release 2018; 276: 30–41. doi: 10.1016/j.jconrel.2018.02.032MarkelcBBellardESersaGJesenkoTPelofySTeissiéJIncreased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions2018276304110.1016/j.jconrel.2018.02.032Open DOISearch in Google Scholar
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388–98. doi: 10.1038/sj.bjc.6604168SersaGJarmTKotnikTCoerAPodkrajsekMSentjurcMVascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma2008983889810.1038/sj.bjc.6604168Open DOISearch in Google Scholar
Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651–657. doi: 10.1016/j.ejso.2018.01.090DjokicMCemazarMPopovicPKosBDezmanRBosnjakMElectrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study20184465165710.1016/j.ejso.2018.01.090Open DOISearch in Google Scholar
Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncl 2020; 46: 1628–1633. doi: 10.1016/j.ejso.2020.04.037EdhemovicIBreceljECemazarMBocNTrotovsekBDjokicMIntraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study2020461628163310.1016/j.ejso.2020.04.037Open DOISearch in Google Scholar
Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, et al. Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy. Basic Clin Pharmacol Toxicol 2018; 123: 247–256. doi: 10.1111/bcpt.13012GroseljAKranjcSBosnjakMKrzanMKosjekTPrevcAVascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy201812324725610.1111/bcpt.13012Open DOISearch in Google Scholar
Curatolo P, Careri R, Simioni A, Campana LG. Cryotherapy, imiquimod, and electrochemotherapy are effective options for kaposi sarcoma: a call for standardization to allow for comparisons and informed decisions. J Cutan Med Surg 2020; 24: 218–9. doi: 10.1177/1203475419893302CuratoloPCareriRSimioniACampanaLGCryotherapy, imiquimod, and electrochemotherapy are effective options for kaposi sarcoma: a call for standardization to allow for comparisons and informed decisions202024218910.1177/1203475419893302Open DOISearch in Google Scholar
Lalanda R, Bartolo J, Carvalhal S, Abecasis N, Farricha V, Sofia R, et al. Cutaneous and subcutaneous Kaposi's sarcoma lesions treated with electrochemotherapy. Int J Dermatol 2023; 62: 115–119. doi: 10.1111/ijd.16261LalandaRBartoloJCarvalhalSAbecasisNFarrichaVSofiaRCutaneous and subcutaneous Kaposi's sarcoma lesions treated with electrochemotherapy20236211511910.1111/ijd.16261Open DOISearch in Google Scholar
Guida M, Campana LG, Curatolo P, Strippoli S, Bonadies A, Grilz G, et al. Local treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study. J Surg Oncol 2016; 114: 246–53. doi: 10.1002/jso.24287GuidaMCampanaLGCuratoloPStrippoliSBonadiesAGrilzGLocal treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study20161142465310.1002/jso.24287Open DOISearch in Google Scholar
Campana LG, Kis E, Bottyán K, Orlando A, de Terlizzi F, Mitsala G, et al. Electrochemotherapy for advanced cutaneous angiosarcoma: a European register-based cohort study from the International Network for Sharing Practices of Electrochemotherapy (InspECT). Int J Surg 2019; 72: 34–42. doi: 10.1016/J.IJSU.2019.10.013CampanaLGKisEBottyánKOrlandoAde TerlizziFMitsalaGElectrochemotherapy for advanced cutaneous angiosarcoma: a European register-based cohort study from the International Network for Sharing Practices of Electrochemotherapy (InspECT)201972344210.1016/J.IJSU.2019.10.013Open DOISearch in Google Scholar
Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D, et al. A Prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma. Cancers 2020; 12: 3778. doi: 10.3390/cancers12123778DjokicMCemazarMBosnjakMDezmanRBadovinacDMiklavcicDA Prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma202012377810.3390/cancers12123778Open DOISearch in Google Scholar
Spiliotis AE, Holländer S, Rudzitis-Auth J, Wagenpfeil G, Eisele R, Nika S, et al. Evaluation of electrochemotherapy with bleomycin in the treatment of colorectal hepatic metastases in a rat model. Cancers 2023; 15: 1598. doi: 10.3390/cancers15051598SpiliotisAEHolländerSRudzitis-AuthJWagenpfeilGEiseleRNikaSEvaluation of electrochemotherapy with bleomycin in the treatment of colorectal hepatic metastases in a rat model202315159810.3390/cancers15051598Open DOISearch in Google Scholar
Gehl J, Geertsen PF. Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy. Eur J Cancer Supp 2006; 4: 35–7. doi: 10.1016/j.ejcsup.2006.07.007GehlJGeertsenPFPalliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy2006435710.1016/j.ejcsup.2006.07.007Open DOISearch in Google Scholar
Lampejo AO, Ghavimi SAA, Hägerling R, Agarwal S, Murfee WL. Lymphatic/blood vessel plasticity: motivation for a future research area based on present and past observations. Am J Physiol Heart Circ Physiol 2023; 324: H109–21. doi: 10.1152/ajpheart.00612.2022LampejoAOGhavimiSAAHägerlingRAgarwalSMurfeeWLLymphatic/blood vessel plasticity: motivation for a future research area based on present and past observations2023324H1092110.1152/ajpheart.00612.2022Open DOISearch in Google Scholar
Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, et al. Histopathological findings in colorectal liver metastases after electrochemotherapy. PLoS One 2017; 12: e0180709. doi: 10.1371/journal.pone.0180709GasljevicGEdhemovicICemazarMBreceljEGadzijevEMMusicMMHistopathological findings in colorectal liver metastases after electrochemotherapy201712e018070910.1371/journal.pone.0180709Open DOISearch in Google Scholar
Wohlgemuth WA, Müller-Wille R, Meyer L, Wildgruber M, Guntau M, Heydt S von der, et al. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body. J Vasc Surg Venous Lymphat Disord 2021; 9: 731–9. doi: 10.1016/J.JVSV.2020.09.009WohlgemuthWAMüller-WilleRMeyerLWildgruberMGuntauMHeydtS von derBleomycin electrosclerotherapy in therapy-resistant venous malformations of the body20219731910.1016/J.JVSV.2020.09.009Open DOISearch in Google Scholar
Krt A, Cemazar M, Lovric D, Sersa G, Jamsek C, Groselj A. Combining superselective catheterization and electrochemotherapy: a new technological approach to the treatment of high-flow head and neck vascular malformations. Front Oncol 2022; 12: 1025270. doi: 10.3389/FONC.2022.1025270KrtACemazarMLovricDSersaGJamsekCGroseljACombining superselective catheterization and electrochemotherapy: a new technological approach to the treatment of high-flow head and neck vascular malformations202212102527010.3389/FONC.2022.1025270Open DOISearch in Google Scholar
Kostusiak M, Murugan S, Muir T. Bleomycin electrosclerotherapy treatment in the management of vascular malformations. Dermatol Surg 2022; 48: 67–71. doi: 10.1097/DSS.0000000000003220KostusiakMMuruganSMuirTBleomycin electrosclerotherapy treatment in the management of vascular malformations202248677110.1097/DSS.0000000000003220Open DOISearch in Google Scholar
Dalmády S, Csoma Z, Besenyi Z, Bottyán K, Oláh J, Kemény L, et al. New treatment option for capillary lymphangioma: bleomycin-based electrochemotherapy of an infant. Pediatrics 2020; 146: e20200566. doi: 10.1542/PEDS.2020-0566DalmádySCsomaZBesenyiZBottyánKOláhJKeményLNew treatment option for capillary lymphangioma: bleomycin-based electrochemotherapy of an infant2020146e2020056610.1542/PEDS.2020-0566Open DOISearch in Google Scholar
McMorrow L, Shaikh M, Kessell G, Muir T. Bleomycin electrosclerotherapy: new treatment to manage vascular malformations. Br J Oral Maxillofac Surg 2017; 55: 977–9. doi: 10.1016/J.BJOMS.2017.10.002McMorrowLShaikhMKessellGMuirTBleomycin electrosclerotherapy: new treatment to manage vascular malformations201755977910.1016/J.BJOMS.2017.10.002Open DOISearch in Google Scholar
Horbach SER, Wolkerstorfer A, Jolink F, Bloemen PR, van der Horst CMAM. Electrosclerotherapy as a novel treatment option for hypertrophic capillary malformations: a randomized controlled pilot trial. Dermatol Surg 2020; 46: 491–8. doi: 10.1097/DSS.0000000000002191HorbachSERWolkerstorferAJolinkFBloemenPRvan der HorstCMAMElectrosclerotherapy as a novel treatment option for hypertrophic capillary malformations: a randomized controlled pilot trial202046491810.1097/DSS.0000000000002191Open DOISearch in Google Scholar
Ge V, Banakh I, Tiruvoipati R, Haji K. Bleomycin-induced pulmonary toxicity and treatment with infliximab: a case report. Clin Case Rep 2018; 6: 2011–4. doi: 10.1002/CCR3.1790GeVBanakhITiruvoipatiRHajiKBleomycin-induced pulmonary toxicity and treatment with infliximab: a case report201862011410.1002/CCR3.1790Open DOISearch in Google Scholar
Benedik J, Ogorevc B, Brezar SK, Cemazar M, Sersa G, Groselj A. Comparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions. Front Oncol 2022; 12: 1011721. doi: 10.3389/FONC.2022.1011721BenedikJOgorevcBBrezarSKCemazarMSersaGGroseljAComparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions202212101172110.3389/FONC.2022.1011721Open DOISearch in Google Scholar
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874–82. doi: 10.1080/0284186X.2018.1454602GehlJSersaGMatthiessenLWMuirTSodenDOcchiniAUpdated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases2018578748210.1080/0284186X.2018.1454602Open DOISearch in Google Scholar